Viewing StudyNCT01058538



Ignite Creation Date: 2024-05-05 @ 10:12 PM
Last Modification Date: 2024-10-26 @ 10:15 AM
Study NCT ID: NCT01058538
Status: COMPLETED
Last Update Posted: 2014-02-25
First Post: 2010-01-27

Brief Title: A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours
Sponsor: Philogen SpA
Organization: Philogen SpA

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumours
Keywords:
Name View
L19 View
Interleukin IL2 monoclonal antibody cytokine tumour targeting solid tumours dose finding renal cell carcinoma fusion protein RCC View